PKU HealthCare Corp Ltd
PKU HealthCare Corp.,Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers products in various categories, including cardiovascular and cerebrovascular, antimicrobial, antipyretic and analgesic, digestive system, oncology, anti-allergic, blood sugar and immunity reg… Read more
PKU HealthCare Corp Ltd (000788) - Net Assets
Latest net assets as of September 2025: CN¥1.61 Billion CNY
Based on the latest financial reports, PKU HealthCare Corp Ltd (000788) has net assets worth CN¥1.61 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.10 Billion) and total liabilities (CN¥484.56 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.61 Billion |
| % of Total Assets | 76.91% |
| Annual Growth Rate | 7.48% |
| 5-Year Change | 17.24% |
| 10-Year Change | 33.95% |
| Growth Volatility | 30.8 |
PKU HealthCare Corp Ltd - Net Assets Trend (1994–2024)
This chart illustrates how PKU HealthCare Corp Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PKU HealthCare Corp Ltd (1994–2024)
The table below shows the annual net assets of PKU HealthCare Corp Ltd from 1994 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.51 Billion | +6.52% |
| 2023-12-31 | CN¥1.42 Billion | +3.25% |
| 2022-12-31 | CN¥1.38 Billion | +3.15% |
| 2021-12-31 | CN¥1.33 Billion | +3.34% |
| 2020-12-31 | CN¥1.29 Billion | +3.62% |
| 2019-12-31 | CN¥1.25 Billion | +3.11% |
| 2018-12-31 | CN¥1.21 Billion | +3.20% |
| 2017-12-31 | CN¥1.17 Billion | +2.89% |
| 2016-12-31 | CN¥1.14 Billion | +0.70% |
| 2015-12-31 | CN¥1.13 Billion | -0.26% |
| 2014-12-31 | CN¥1.13 Billion | -3.78% |
| 2013-12-31 | CN¥1.18 Billion | +7.03% |
| 2012-12-31 | CN¥1.10 Billion | +5.81% |
| 2011-12-31 | CN¥1.04 Billion | +22.42% |
| 2010-12-31 | CN¥849.59 Million | +47.11% |
| 2009-12-31 | CN¥577.50 Million | +82.62% |
| 2008-12-31 | CN¥316.23 Million | +4.02% |
| 2007-12-31 | CN¥304.01 Million | +13.28% |
| 2006-12-31 | CN¥268.36 Million | +21.80% |
| 2005-12-31 | CN¥220.32 Million | +6.29% |
| 2004-12-31 | CN¥207.30 Million | +21.11% |
| 2003-12-31 | CN¥171.16 Million | +37.36% |
| 2002-12-31 | CN¥124.61 Million | -56.77% |
| 2001-12-31 | CN¥288.21 Million | -21.54% |
| 2000-12-31 | CN¥367.32 Million | -20.09% |
| 1999-12-31 | CN¥459.68 Million | -20.79% |
| 1998-12-31 | CN¥580.32 Million | +3.89% |
| 1997-12-31 | CN¥558.57 Million | +120.76% |
| 1996-12-31 | CN¥253.02 Million | +25.73% |
| 1995-12-31 | CN¥201.24 Million | +15.56% |
| 1994-12-31 | CN¥174.14 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PKU HealthCare Corp Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 65705724000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥657.06 Million | 43.38% |
| Common Stock | CN¥595.99 Million | 39.35% |
| Other Comprehensive Income | CN¥180.36 Million | 11.91% |
| Other Components | CN¥81.35 Million | 5.37% |
| Total Equity | CN¥1.51 Billion | 100.00% |
PKU HealthCare Corp Ltd Competitors by Market Cap
The table below lists competitors of PKU HealthCare Corp Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
The York Water Company
NASDAQ:YORW
|
$420.66 Million |
|
SKF India Limited
NSE:SKFINDIA
|
$420.75 Million |
|
Stanmore Resources Limited
PINK:STMRF
|
$420.76 Million |
|
Verallia SAS
LSE:0ABH
|
$420.84 Million |
|
Darma Henwa Tbk
JK:DEWA
|
$420.30 Million |
|
FASTIGHETSBOL.EMILSHUS B
F:Z2A0
|
$419.98 Million |
|
Ambiq Micro, Inc.
NYSE:AMBQ
|
$419.98 Million |
|
Jiangsu Kuangshun Photosensitivity New-Material Stock Co Ltd
SHE:300537
|
$419.89 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PKU HealthCare Corp Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,422,057,522 to 1,514,755,082, a change of 92,697,560 (6.5%).
- Net income of 137,992,604 contributed positively to equity growth.
- Dividend payments of 46,454,044 reduced retained earnings.
- Other comprehensive income increased equity by 180,362,987.
- Other factors decreased equity by 179,203,987.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥137.99 Million | +9.11% |
| Dividends Paid | CN¥46.45 Million | -3.07% |
| Other Comprehensive Income | CN¥180.36 Million | +11.91% |
| Other Changes | CN¥-179.20 Million | -11.83% |
| Total Change | CN¥- | 6.52% |
Book Value vs Market Value Analysis
This analysis compares PKU HealthCare Corp Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.36x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 18.74x to 2.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | CN¥0.32 | CN¥5.99 | x |
| 1995-12-31 | CN¥0.37 | CN¥5.99 | x |
| 1996-12-31 | CN¥0.46 | CN¥5.99 | x |
| 1997-12-31 | CN¥1.03 | CN¥5.99 | x |
| 1998-12-31 | CN¥1.06 | CN¥5.99 | x |
| 1999-12-31 | CN¥0.84 | CN¥5.99 | x |
| 2000-12-31 | CN¥0.67 | CN¥5.99 | x |
| 2001-12-31 | CN¥0.53 | CN¥5.99 | x |
| 2002-12-31 | CN¥0.39 | CN¥5.99 | x |
| 2003-12-31 | CN¥0.53 | CN¥5.99 | x |
| 2004-12-31 | CN¥0.64 | CN¥5.99 | x |
| 2005-12-31 | CN¥0.68 | CN¥5.99 | x |
| 2006-12-31 | CN¥0.54 | CN¥5.99 | x |
| 2007-12-31 | CN¥0.54 | CN¥5.99 | x |
| 2008-12-31 | CN¥0.49 | CN¥5.99 | x |
| 2009-12-31 | CN¥0.94 | CN¥5.99 | x |
| 2010-12-31 | CN¥1.35 | CN¥5.99 | x |
| 2011-12-31 | CN¥1.65 | CN¥5.99 | x |
| 2012-12-31 | CN¥1.81 | CN¥5.99 | x |
| 2013-12-31 | CN¥1.91 | CN¥5.99 | x |
| 2014-12-31 | CN¥2.05 | CN¥5.99 | x |
| 2015-12-31 | CN¥1.81 | CN¥5.99 | x |
| 2016-12-31 | CN¥1.82 | CN¥5.99 | x |
| 2017-12-31 | CN¥2.06 | CN¥5.99 | x |
| 2018-12-31 | CN¥2.15 | CN¥5.99 | x |
| 2019-12-31 | CN¥2.10 | CN¥5.99 | x |
| 2020-12-31 | CN¥2.18 | CN¥5.99 | x |
| 2021-12-31 | CN¥2.25 | CN¥5.99 | x |
| 2022-12-31 | CN¥2.32 | CN¥5.99 | x |
| 2023-12-31 | CN¥2.39 | CN¥5.99 | x |
| 2024-12-31 | CN¥2.54 | CN¥5.99 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PKU HealthCare Corp Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.11%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.70%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 1.51x
- Recent ROE (9.11%) is above the historical average (2.25%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 31.55% | 17.24% | 0.74x | 2.46x | CN¥37.52 Million |
| 1995 | 26.39% | 16.95% | 0.56x | 2.80x | CN¥32.98 Million |
| 1996 | 20.47% | 16.27% | 0.51x | 2.49x | CN¥26.48 Million |
| 1997 | 10.05% | 15.04% | 0.40x | 1.65x | CN¥280.76K |
| 1998 | 3.75% | 7.65% | 0.28x | 1.77x | CN¥-36.29 Million |
| 1999 | -10.82% | -21.67% | 0.24x | 2.11x | CN¥-95.72 Million |
| 2000 | -25.14% | -32.89% | 0.29x | 2.60x | CN¥-129.09 Million |
| 2001 | 1.64% | 1.75% | 0.30x | 3.13x | CN¥-24.09 Million |
| 2002 | -122.52% | -57.71% | 0.34x | 6.31x | CN¥-165.13 Million |
| 2003 | 2.95% | 1.55% | 0.50x | 3.80x | CN¥-12.07 Million |
| 2004 | 5.84% | 2.83% | 0.56x | 3.72x | CN¥-8.62 Million |
| 2005 | 5.90% | 2.76% | 0.66x | 3.24x | CN¥-9.03 Million |
| 2006 | 4.95% | 2.65% | 0.68x | 2.75x | CN¥-13.56 Million |
| 2007 | 4.94% | 2.57% | 0.72x | 2.67x | CN¥-14.43 Million |
| 2008 | 4.82% | 2.60% | 0.69x | 2.69x | CN¥-15.44 Million |
| 2009 | 12.14% | 7.43% | 0.67x | 2.45x | CN¥11.52 Million |
| 2010 | 33.30% | 20.79% | 0.66x | 2.44x | CN¥188.94 Million |
| 2011 | 11.50% | 5.89% | 0.71x | 2.74x | CN¥15.02 Million |
| 2012 | 7.16% | 3.91% | 0.54x | 3.42x | CN¥-30.16 Million |
| 2013 | 6.82% | 3.37% | 0.55x | 3.70x | CN¥-36.36 Million |
| 2014 | -2.44% | -1.20% | 0.49x | 4.15x | CN¥-138.11 Million |
| 2015 | 2.21% | 1.24% | 0.64x | 2.76x | CN¥-88.27 Million |
| 2016 | 1.10% | 0.61% | 1.01x | 1.79x | CN¥-101.67 Million |
| 2017 | 2.91% | 1.60% | 1.03x | 1.76x | CN¥-83.37 Million |
| 2018 | 3.72% | 1.95% | 1.08x | 1.76x | CN¥-76.22 Million |
| 2019 | 4.01% | 2.00% | 1.02x | 1.97x | CN¥-75.00 Million |
| 2020 | 3.02% | 1.98% | 0.86x | 1.78x | CN¥-90.52 Million |
| 2021 | 3.22% | 1.93% | 0.88x | 1.90x | CN¥-90.87 Million |
| 2022 | 4.02% | 2.68% | 0.79x | 1.91x | CN¥-82.64 Million |
| 2023 | 3.12% | 2.02% | 0.90x | 1.71x | CN¥-97.85 Million |
| 2024 | 9.11% | 6.70% | 0.90x | 1.51x | CN¥-13.48 Million |
Industry Comparison
This section compares PKU HealthCare Corp Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $2,123,990,643
- Average return on equity (ROE) among peers: -0.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PKU HealthCare Corp Ltd (000788) | CN¥1.61 Billion | 31.55% | 0.30x | $420.45 Million |
| Shenzhen Neptunus Bioengineering Co Ltd (000078) | $6.47 Billion | 9.88% | 3.77x | $616.08 Million |
| Anhui Fengyuan Pharmaceutical Co Ltd (000153) | $1.18 Billion | 2.74% | 0.95x | $320.56 Million |
| Shan Dong Dong-E E-Jiao Co Ltd (000423) | $10.33 Billion | 15.07% | 0.27x | $3.03 Billion |
| Wedge Industrial Co Ltd (000534) | $298.72 Million | 1.96% | 0.38x | $1.77 Billion |
| Yunnan Baiyao Group Co Ltd (000538) | $35.11 Million | 18.13% | 0.80x | $5.62 Billion |
| Hainan Haiyao Co Ltd (000566) | $353.98 Million | -9.58% | 0.80x | $702.18 Million |
| Tus Pharmaceutical Group Co Ltd (000590) | $269.51 Million | -61.02% | 1.05x | $317.08 Million |
| Northeast Pharmaceutical Group Co Ltd (000597) | $927.49 Million | 2.65% | 1.38x | $425.60 Million |
| Jilin Aodong Pharmaceutical Group Co Ltd (000623) | $1.11 Billion | 7.32% | 0.29x | $2.05 Billion |
| Renhe Pharmacy Co Ltd (000650) | $261.49 Million | 10.60% | 0.82x | $777.45 Million |